Description
abm | GALE Stable Knockout HEK293T (Clone 4) Cell Line | T6150
The GALE gene encodes UDP-galactose-4 epimerase which operates in the Leloir pathway, the primary pathway for galactose metabolism. This pathway is critical for the generation of UDP-sugars and catalyzes UDP-glucose to UDP-galactose and UDP-N acetylgalactosamine to UDP N-acetylgalactosamine which serve as precursors for O-linked glycosylation and as the major metabolism pathway for galactose. As this cell line is derived from a human source, it may be useful in the study of glycosylation and how it is affected during instances of disease.
Biosafety:
II
Organism:
Human
Source Organ:
Kidney
Growth Properties:
Adherent
Morphology:
Epithelial
Clones:
N/A
Passage Number:
N/A
Population Doner:
N/A
Seeding Density:
N/A
Markers:
N/A
Applications:
For Research Use Only
Doner Gender:
Embryo
Donor Ethnicity:
N/A
Knockdown Method:
N/A
Induction:
N/A
Overexpression:
N/A
Freeze Thaw:
N/A
Propagation:
The base medium for this cell line is Prigrow III available from abm
Preservation:
N/A
Quality Control:
1) Confirmed CRISPR-Cas9 presence by GFP examination (Figure 1). 2) Confirmed GALE knockout through western blot analysis and sequencing (Figure S1). Tested O-glycosylation levels through enzymatic activity on the substrate SIVmac239 gp120 via Western Blot and SDS gel analysis (Figure 3)
Tumorgenicn:
N/A
Shipping Conditions:
Dry Ice
Storage Contidions:
-180°C